Please login to the form below

Not currently logged in
Email:
Password:

data transparency

This page shows the latest data transparency news and features for those working in and with pharma, biotech and healthcare.

Safety first: AI adoption in the healthcare sector

Safety first: AI adoption in the healthcare sector

Poor results and outcomes, misuse, a reliance on bad data, privacy impacts, a perceived lack of transparency, discrimination and an adverse effect on employment could all impact AI’s potential. ... may arise from bias in data, as well as concerns about

Latest news

  • Audit exposes gaps in pharma's promises on trial transparency Audit exposes gaps in pharma's promises on trial transparency

    transparency, followed by LEO Pharma, Takeda, Pfizer, Novartis, Novo Nordisk, Boehringer Ingelheim, Amgen, Merck &Co and AbbVie. ... CSRs) and individual patient data (IPD) - and gauges how well they meet a reference standard.

  • US scientists still wary of Gottlieb's industry ties US scientists still wary of Gottlieb's industry ties

    Among other key findings were that the majority of participants agreed that the FDA should work on data transparency - including releasing information on both approved and denied drugs - while more than

  • Nearly half of all clinical trials not published Nearly half of all clinical trials not published

    Commenting on the research, director general of European pharma body EFPIA, Richard Bergström said: “ On the journey towards clinical data transparency, EFPIA and its members are ready to be held to ... EFPIA supports the intent of the new EU Clinical

  • Daiichi Sankyo begins sharing clinical trial data online Daiichi Sankyo begins sharing clinical trial data online

    Daiichi Sankyo has joined many of its industry peers in their transparency efforts by signing up to a portal that provides anonymised patient-level data on request to qualified researchers. ... Since May 2013 the AllTrials transparency campaign says data

  • Harnessing clinical data Harnessing clinical data

    Investigator registry. Paediatric trial efficiencies. Clinical trial diversification. Clinical data transparency. ... Quality management systems. Electronic labels. Placebo and standard of care data sharing/li>.

More from news
Approximately 19 fully matching, plus 71 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2)

    Jackie is convinced the firm will produce compelling data from its ongoing studies. ... and in supporting ‘open science’and data transparency.

  • Protecting patient privacy Protecting patient privacy

    Accurate risk measurement. Support for process automation. Indeed, EMA is encouraging companies to move away from document redaction towards other data anonymisation approaches. ... It is not in the spirit of clinical data transparency and it adds the

  • Exploring serious market access roadblocks for rare bleeding disorders Exploring serious market access roadblocks for rare bleeding disorders

    Healthcare policymakers and advocacy groups need to have consistent and structured patient data. ... One source points out how transparency of individual patient data is essential to personalise treatments and improve patient health, as it allows

  • LEO: Patients benefit from transparency LEO: Patients benefit from transparency

    We have a scientific and ethnical responsibility to make clinical trial data available because of this.”. ... LEO Pharma announced its commitments to trial transparency back in 2013, following a workshop on clinical trial data and transparency

  • The Heart of the Matter 9: Context is king The Heart of the Matter 9: Context is king

    The transparency agenda has spawned an ever-increasing expansion of the ʻgrey literatureʼ. ... As the combination of digital innovation and data transparency transforms stakeholder engagement, companies are increasingly seeking new ways to cut through

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Sanofi CEO Viehbacher to head EFPIA Sanofi CEO Viehbacher to head EFPIA

    One of the most pressing matters for EFPIA is the seemingly inevitable trend towards transparency of trial data, and Viehbacher has already commented on the subject.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics